Aviko Radiopharmaceuticals
The startup develops boron neutron capture therapy (BNCT) technology that precisely targets and delivers boron to cancer cells, effectively eliminating solid tumors while preserving healthy tissue. This approach enhances treatment efficacy for various cancers, improving patient outcomes through targeted therapy.
- Biotechnology
Updated 5 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops boron neutron capture therapy (BNCT) technology that precisely targets and delivers boron to cancer cells, effectively eliminating solid tumors while preserving healthy tissue. This approach enhances treatment efficacy for various cancers, improving patient outcomes through targeted therapy.